Research ArticleOriginal Article

Akt isoforms differentially provide for chemoresistance in prostate cancer

Bo Ma, Hanshuang Shao, Xia Jiang, Zhou Wang, Chuanyue (Cary) Wu, Diana Whaley and Alan Wells
Cancer Biology & Medicine May 2022, 19 (5) 635-650; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0747

Article Information

vol. 19 no. 5 635-650
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2020.0747
PubMed 
34591413
Published By 
Cancer Biology & Medicine
History 
  • Received December 7, 2020
  • Accepted April 1, 2021
  • Published online June 24, 2022.
Copyright & Usage 
Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Bo Ma1,2,3⇑,
  2. Hanshuang Shao2,3,
  3. Xia Jiang4,
  4. Zhou Wang2,5,6,7,
  5. Chuanyue (Cary) Wu2,
  6. Diana Whaley2,3 and
  7. Alan Wells2,3,7⇑
  1. 1Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou 221002, China
  2. 2Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, USA
  3. 3Pittsburgh VA Healthcare System, Pittsburgh, PA 15213, USA
  4. 4Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA 15261, USA
  5. 5Department of Urology, University of Pittsburgh, Pittsburgh, PA 15261, USA
  6. 6Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA
  7. 7UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA
  1. Correspondence to: Bo Ma and Alan Wells, E-mail: boma{at}xzhmu.edu.cn and wellsa{at}upmc.edu
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords